Home/Filings/4/0001615219-17-000034
4//SEC Filing

Flex Pharma, Inc. 4

Accession 0001615219-17-000034

$SLRXCIK 0001615219operating

Filed

May 29, 8:00 PM ET

Accepted

May 30, 12:55 PM ET

Size

8.7 KB

Accession

0001615219-17-000034

Insider Transaction Report

Form 4
Period: 2017-05-26
McVicar William K.
President, R&D
Transactions
  • Award

    Stock Option (right to buy)

    2017-05-26+200,000200,000 total
    Exercise: $3.37Exp: 2027-05-26Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the total shares underlying this option vest on April 5, 2018 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.

Issuer

Flex Pharma, Inc.

CIK 0001615219

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001615219

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 12:55 PM ET
Size
8.7 KB